Follow
Jérome Rollin
Jérome Rollin
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Voltage-gated sodium channels potentiate the invasive capacities of human non-small-cell lung cancer cell lines
S Roger, J Rollin, A Barascu, P Besson, PI Raynal, S Iochmann, M Lei, ...
The international journal of biochemistry & cell biology 39 (4), 774-786, 2007
2182007
Steroid receptor RNA activator protein binds to and counteracts SRA RNA-mediated activation of MyoD and muscle differentiation
F Hube, G Velasco, J Rollin, D Furling, C Francastel
Nucleic acids research 39 (2), 513-525, 2011
1712011
Dnmt3b recruitment through E2F6 transcriptional repressor mediates germ-line gene silencing in murine somatic tissues
G Velasco, F Hubé, J Rollin, D Neuillet, C Philippe, H Bouzinba-Segard, ...
Proceedings of the National Academy of Sciences 107 (20), 9281-9286, 2010
1562010
Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer
J Rollin, S Régina, P Vourc’h, S Iochmann, C Bléchet, P Reverdiau, ...
Lung cancer 56 (2), 273-280, 2007
1472007
PF4 immunoassays in vaccine-induced thrombotic thrombocytopenia
C Vayne, J Rollin, Y Gruel, C Pouplard, H Galinat, O Huet, V Mémier, ...
New England Journal of Medicine 385 (4), 376-378, 2021
1112021
Tissue factor expression in non-small cell lung cancer: relationship with vascular endothelial growth factor expression, microvascular density, and K-ras mutation
S Regina, J Rollin, C Bléchet, S Iochmann, P Reverdiau, Y Gruel
Journal of Thoracic Oncology 3 (7), 689-697, 2008
1062008
Increased Tissue Factor Expression Is Associated with Reduced Survival in Non–Small Cell Lung Cancer and with Mutations of TP53 and PTEN
S Regina, JB Valentin, S Lachot, E Lemarié, J Rollin, Y Gruel
Clinical chemistry 55 (10), 1834-1842, 2009
1022009
Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer
J Rollin, S Iochmann, C Blechet, F Hube, S Regina, S Guyetant, ...
British journal of cancer 92 (4), 775-783, 2005
1022005
Pathophysiology and diagnosis of drug-induced immune thrombocytopenia
C Vayne, EA Guéry, J Rollin, T Baglo, R Petermann, Y Gruel
Journal of clinical medicine 9 (7), 2212, 2020
972020
Increased risk of thrombosis in FcγRIIA 131RR patients with HIT due to defective control of platelet activation by plasma IgG2
J Rollin, C Pouplard, H Cheng Sung, D Leroux, A Saada, ...
Blood, The Journal of the American Society of Hematology 125 (15), 2397-2404, 2015
962015
p63 regulates human keratinocyte proliferation via MYC-regulated gene network and differentiation commitment through cell adhesion-related gene network
N Wu, J Rollin, I Masse, J Lamartine, X Gidrol
Journal of Biological Chemistry 287 (8), 5627-5638, 2012
942012
KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer
C Planque, M de Monte, S Guyetant, J Rollin, C Desmazes, V Panel, ...
Biochemical and biophysical research communications 329 (4), 1260-1266, 2005
892005
Polymorphisms of protein tyrosine phosphatase CD148 influence FcγRIIA-dependent platelet activation and the risk of heparin-induced thrombocytopenia
J Rollin, C Pouplard, MP Gratacap, D Leroux, MA May, M Aupart, ...
Blood, The Journal of the American Society of Hematology 120 (6), 1309-1316, 2012
662012
Risk factors for heparin-induced thrombocytopenia: focus on Fcγ receptors
J Rollin, C Pouplard, Y Gruel
Thrombosis and haemostasis 116 (11), 799-805, 2016
652016
Effectiveness of a new immuno-assay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies
C Pouplard, D Leroux, S Regina, J Rollin, Y Gruel
Thrombosis and haemostasis 103 (01), 145-150, 2010
652010
Bevacizumab pharmacokinetics influence overall and progression-free survival in metastatic colorectal cancer patients
M Caulet, T Lecomte, O Bouché, J Rollin, V Gouilleux-Gruart, N Azzopardi, ...
Clinical pharmacokinetics 55, 1381-1394, 2016
622016
Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin‐induced thrombocytopenia antibodies
C Vayne, EA Guery, C Kizlik‐Masson, J Rollin, A Bauters, Y Gruel, ...
British journal of haematology 179 (5), 811-819, 2017
592017
Heparin-induced thrombocytopenia in cardiac surgery patients
AM Pishko, A Cuker
Seminars in thrombosis and hemostasis 43 (07), 691-698, 2017
592017
A genome-wide association study of heparin-induced thrombocyto-penia using an electronic medical record
JH Karnes, RM Cronin, J Rollin, A Teumer, C Pouplard, CM Shaffer, ...
Thrombosis and haemostasis 113 (04), 772-781, 2015
532015
Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells
F Hubé, P Reverdiau, S Iochmann, J Rollin, C Cherpi-Antar, Y Gruel
Walter de Gruyter 384 (7), 1029-1034, 2003
452003
The system can't perform the operation now. Try again later.
Articles 1–20